Global ETD Search

Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.

Results

Showing 1 to 20 of 52 for “"Immunoengineering"”.

  1. Immunoengineering nanoparticles for mucosal drug and vaccine treatment of sexually transmitted infections

    Sexually transmitted infections (STIs) are a major burden on human health worldwide, accounting for nearly 1 million infections daily. Women’s sexual and reproductive health is disproportionately impacted by the most commonly transmitted pathogens, including Hepatitis B, human simplex virus (HSV), …

    washington Repository record for Immunoengineering nanoparticles for mucosal drug and vaccine treatment of sexually transmitted infections (opens in a new tab)

  2. OPTIMIZATION OF METHODS FOR MHC-IG SYNTHESIS, PURIFICATION, AND EVALUATION FOR T CELL IMMUNOENGINEERING

    Cytotoxic CD8+ T cells are integral to the adaptive immune response towards pathogens and cancer, yet these cells require many external signals to activate and form memory cells. Efficient activation and persistence of these lymphocytes is hindered by immunodominance, immunosuppression, and …

    jhu Repository record for OPTIMIZATION OF METHODS FOR MHC-IG SYNTHESIS, PURIFICATION, AND EVALUATION FOR T CELL IMMUNOENGINEERING (opens in a new tab)

  3. Lipid nanoparticle-based nucleic acid delivery technologies for ex vivo and in vivo immunoengineering

    Ribonucleic acid (RNA) has taken the field of drug delivery by storm as an exciting cargo class for gene modulation, particularly in the wake of the global deployment of messenger RNA (mRNA) vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The full potential of …

    penn Repository record for Lipid nanoparticle-based nucleic acid delivery technologies for ex vivo and in vivo immunoengineering (opens in a new tab)

  4. The Immunoengineering Toolbox: A Set of Thermoresponsive Biopolymers for Sustained Delivery of Cancer Immunotherapies

    <p>Therapeutic cancer vaccines have the potential to revolutionize cancer treatment by providing systemic control of both local and metastatic malignancies. However, stimulating antitumor immune responses in patients with cancer has proven difficult and the success rate associated with cancer …

    duke Repository record for The Immunoengineering Toolbox: A Set of Thermoresponsive Biopolymers for Sustained Delivery of Cancer Immunotherapies (opens in a new tab)

  5. Novel Synthetic Circuits for Cellular Theranostic Applications

    … 600,000 deaths in the United States each year. Immunoengineering, the process of harnessing a patient's immune system to treat disease, has proven to be a promising therapeutic approach for cancer. For example, the FDA has approved seven chimeric antigen receptor T-cell (CAR-T) therapies. …

    rowan Repository record for Novel Synthetic Circuits for Cellular Theranostic Applications (opens in a new tab)

  6. ADVANCING NEXT-GENERATION POLYMERIC PARTICLE ENGINEERING FOR IMMUNOMODULATION AND GENE DELIVERY THERAPEUTICS IN ONCOLOGY AND AUTOIMMUNITY

    The field of immunoengineering is rapidly expanding, fueled by breakthroughs in oncology and autoimmune therapies such as immune checkpoint inhibitors and chimeric antigen receptor (CAR) T-cell treatments. These innovative strategies harness the immune system's power to target and eliminate cancer …

    jhu Repository record for ADVANCING NEXT-GENERATION POLYMERIC PARTICLE ENGINEERING FOR IMMUNOMODULATION AND GENE DELIVERY THERAPEUTICS IN ONCOLOGY AND AUTOIMMUNITY (opens in a new tab) Embargoed until 2028-12-01

  7. PROGRAMMABLE EXPANSION OF HUMAN ANTIGEN-SPECIFIC CYTOTOXIC CD4+ T CELLS USING NANOPARTICLE ARTIFICIAL ANTIGEN-PRESENTING CELLS

    … the understanding of CD4 CTL biology and develop immunoengineering strategies to selectively expand antigen-specific CD4+ T cells for therapeutic applications. Here, I developed a nanoscale artificial antigen-presenting cell (aAPC) platform designed to provide defined antigen-specific and …

    jhu Repository record for PROGRAMMABLE EXPANSION OF HUMAN ANTIGEN-SPECIFIC CYTOTOXIC CD4+ T CELLS USING NANOPARTICLE ARTIFICIAL ANTIGEN-PRESENTING CELLS (opens in a new tab) Embargoed until 2030-05-01

  8. Monodisperse polymeric microparticles as artificial antigen presenting cells for cancer immunotherapy

    … drug delivery vehicles to devices for cellular immunoengineering. The microfluidic continuous manufacture method of polymeric particle synthesis is a versatile platform for particles composed of different materials and payloads.

    jhu Repository record for Monodisperse polymeric microparticles as artificial antigen presenting cells for cancer immunotherapy (opens in a new tab)

  9. Hydrogel-Based Viability and Migration Studies of Dendritic Cells for Immunotherapeutic Applications

    … In recent decades, research in biomaterials and immunoengineering has accelerated significantly, driving the development of advanced therapies for cancer and autoimmune diseases. Dendritic cells (DCs) have emerged as a key focus in pharmaceutical and biological therapeutics due to their ability …

    gatech Repository record for Hydrogel-Based Viability and Migration Studies of Dendritic Cells for Immunotherapeutic Applications (opens in a new tab)

  10. Optimization of IL-10 incorporation for Dendritic cells embedded in PEG-4MAL hydrogels.

    … translational research in biomaterials and immunoengineering has been appreciated by science, which is corroborated by the development of novel advanced therapies to treat cancer, autoimmunity, and other immune-related pathologies. Dendritic cells (DCs) have been at the core center of …

    gatech Repository record for Optimization of IL-10 incorporation for Dendritic cells embedded in PEG-4MAL hydrogels. (opens in a new tab)

  11. Biomimetic Polymeric Particle Therapeutics for Enhanced Drug Delivery and Cancer Immunotherapy

    … enhanced drug delivery and cancer immunotherapy. Immunoengineering is a particularly clinically relevant application for particle therapeutics due to the recent clinical success of cancer immunotherapy and the pervasive role of the immune system in human disease. Chapter one outlines the guiding …

    jhu Repository record for Biomimetic Polymeric Particle Therapeutics for Enhanced Drug Delivery and Cancer Immunotherapy (opens in a new tab)

  12. Protein nanoparticle vaccines

    … further investigations in the broader field of immunoengineering.

    gatech Repository record for Protein nanoparticle vaccines (opens in a new tab)

  13. THE APPLICATION OF TOLEROGENIC MICROPARTICLES AND REGENERATIVE TREG-EXPANDING PARTICLES ON AUTOIMMUNE DISEASES

    … clinical need for the development of innovative immunoengineering technologies for the treatment of autoimmune diseases, such as type 1 diabetes and multiple sclerosis. The prominent role of regulatory T cells (Tregs) in restoring and maintaining immune tolerance has been of interest for the …

    jhu Repository record for THE APPLICATION OF TOLEROGENIC MICROPARTICLES AND REGENERATIVE TREG-EXPANDING PARTICLES ON AUTOIMMUNE DISEASES (opens in a new tab)

  14. Engineered Bispecific Antibodies and Immune Cytokine Mimetics for Therapeutic Applications

    Emerging immunoengineering therapies have shown great pharmaceutical potential due to their high efficacy and high specificity. This thesis is composed of two projects focusing on engineering immunological protein therapies, which I have been working on for two years in the Johns Hopkins University …

    jhu Repository record for Engineered Bispecific Antibodies and Immune Cytokine Mimetics for Therapeutic Applications (opens in a new tab)

  15. Immunomodulation in Experimental Autoimmune Encephalomyelitis Using PEG-4MAL Hydrogel with Dendritic Cells: Effects of Variable Stimuli on Cell Maturation

    … the recent decades, research in biomaterials and immunoengineering has been investigated at a higher rate than previous years in science. Due to this there has been a surge of development in advanced therapies to treat cancers, autoimmune diseases, and other possible immune-related pathologies. …

    gatech Repository record for Immunomodulation in Experimental Autoimmune Encephalomyelitis Using PEG-4MAL Hydrogel with Dendritic Cells: Effects of Variable Stimuli on Cell Maturation (opens in a new tab)

  16. Engineering macrophages for self-regulated, localized delivery of anti-inflammatory biologics

    Immunoengineering continues to revolutionize healthcare, generating new approaches for treating previously intractable diseases. In chronic inflammatory diseases such as rheumatoid arthritis (RA), a chronic autoimmune disease characterized by joint inflammation and destruction, anti-cytokine …

    wustl Repository record for Engineering macrophages for self-regulated, localized delivery of anti-inflammatory biologics (opens in a new tab)

  17. Immunomodulation Following Severe Musculoskeletal Trauma to Improve Functional Regeneration

    … such knowledge can enable design of effective immunoengineering strategies to improve functional regeneration has not been rigorously tested. Finally, well-characterized animal models that mimic these conditions and that could allow for a better understanding of the interaction between …

    gatech Repository record for Immunomodulation Following Severe Musculoskeletal Trauma to Improve Functional Regeneration (opens in a new tab)

  18. DEVELOPING ANTIBODY DRUG CONJUGATE PLATFORMS VIA METABOLIC AND GENETIC GLYCOENGINEERING

    Antibody drug conjugates (ADCs) combine the unique specificity of antibodies with the substantial cytotoxicity of traditional chemotherapies, creating a relatively new class of therapeutics that has yet to see its full potential. Similarly, a canonical N-glycan has been long recognized for its …

    jhu Repository record for DEVELOPING ANTIBODY DRUG CONJUGATE PLATFORMS VIA METABOLIC AND GENETIC GLYCOENGINEERING (opens in a new tab)

  19. POLYMERIC PARTICLE-BASED DRUG DELIVERY PLATFORMS FOR IMMUNE MODULATION

    Biologics, small molecule drugs, and nucleic acids that selectively activate or suppress the immune system offer some of the most promising new treatments for cancer and autoimmunity. New approaches to deliver these therapies to their target cell populations in a safe and controlled way are needed …

    jhu Repository record for POLYMERIC PARTICLE-BASED DRUG DELIVERY PLATFORMS FOR IMMUNE MODULATION (opens in a new tab)

  20. Biodegradable Nano- and Microparticles for Gene Delivery and Immune Activation

    This thesis discusses the development of biodegradable polymers, nanoparticles, and microparticles for gene delivery and immune activation. The bulk of this thesis focuses on trying to understand basic principles important to the development of polymer-based gene delivery nanoparticles and …

    jhu Repository record for Biodegradable Nano- and Microparticles for Gene Delivery and Immune Activation (opens in a new tab)

Page 1 of 3